Optimal experiment design for PET quantification of receptor concentration

The mathematical models used to analyze positron emission tomography (PET) data obtained for receptor quantitation have many unknown parameters which must be estimated from the data. Obtaining unique and precise estimates of the model parameters from PET data is difficult as a result of the complex interdependence of the parameters. Here the authors address the task of estimating the concentration of myocardial beta-adrenergic receptors using unlabeled and (18)F-labeled S(-)-fluorocarazolol as the receptor ligand. For a three-injection study the authors have optimized the ligand injection times and dosages using the D-optimal criterion for estimating receptor concentration. They found that in optimizing a three-injection experimental design, the dose of ligand in the third injection approaches zero so that the optimal three-injection design is actually a two-injection experiment. Using this optimal experiment, the authors demonstrate estimates of receptor concentration that are almost five times as precise as compared to an empirically designed three-injection experiment.

[1]  G M Saidel,et al.  Optimal design of experiments to estimate LDL transport parameters in arterial wall. , 1991, The American journal of physiology.

[2]  T. Brubaker,et al.  Nonlinear Parameter Estimation , 1979 .

[3]  J R Votaw,et al.  Failure of the three compartment model to describe the pharmacokinetics in brain of a high affinity substituted benzamide , 1993, Synapse.

[4]  K. Krohn,et al.  Goodness-of-fit and local identifiability of a receptor-binding radio-pharmacokinetic system , 1992, IEEE Transactions on Biomedical Engineering.

[5]  D. Barber.  The use of principal components in the quantitative analysis of gamma camera dynamic studies. , 1980, Physics in medicine and biology.

[6]  M. Mintun,et al.  A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography , 1984, Annals of neurology.

[7]  L. Farde,et al.  Kinetic Analysis of Central [11C]Raclopride Binding to D2-Dopamine Receptors Studied by PET—A Comparison to the Equilibrium Analysis , 1989, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[8]  Bengt Winblad,et al.  Reduced number of [3H]nicotine and [3H]acetylcholine binding sites in the frontal cortex of Alzheimer brains , 1986, Neuroscience Letters.

[9]  D. Marquardt.  An Algorithm for Least-Squares Estimation of Nonlinear Parameters , 1963 .

[10]  R H Huesman,et al.  Dynamic PET Data Analysis , 1986, Journal of computer assisted tomography.

[11]  B R Zeeberg,et al.  Accuracy of in vivo neuroreceptor quantification by PET and review of steady-state, transient, double injection, and equilibrium models. , 1988, IEEE transactions on medical imaging.

[12]  F. Miraldi,et al.  Specific beta-adrenergic receptor binding of carazolol measured with PET. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[13]  J C Mazziotta,et al.  Models for in vivo Kinetic Interactions of Dopamine D2-Neuroreceptors and 3-(2'-[18F]Fluoroethyl)Spiperone Examined with Positron Emission Tomography , 1989, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[14]  John A. Nelder,et al.  A Simplex Method for Function Minimization , 1965, Comput. J..

[15]  J Delforge,et al.  Experimental design optimisation: theory and application to estimation of receptor model parameters using dynamic positron emission tomography. , 1989, Physics in medicine and biology.

[16]  S. Gauthier,et al.  Comparative Alterations of Nicotinic and Muscarinic Binding Sites in Alzheimer's and Parkinson's Diseases , 1992, Journal of neurochemistry.

[17]  J C Mazziotta,et al.  A Double-Injection Technique for in vivo Measurement of Dopamine D2-Receptor Density in Monkeys with 3-(2'-[18F] Fluoroethyl)Spiperone and Dynamic Positron Emission Tomography , 1989, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[18]  Alan C. Evans,et al.  Minimisation of parameter estimation errors in dynamic PET: choice of scanning schedules. , 1989, Physics in medicine and biology.

[19]  J. Delforge,et al.  Identifiability analysis and parameter identification of an in vivo ligand-receptor model from PET data , 1990, IEEE Transactions on Biomedical Engineering.

[20]  Bengt Winblad,et al.  Change in nicotinic receptor subtypes in temporal cortex of Alzheimer brains , 1988, Neuroscience Letters.

[21]  G. L. Brownell,et al.  Estimation of the Local Statistical Noise in Emission Computed Tomography , 1982, IEEE Transactions on Medical Imaging.

[22]  M H Nathanson,et al.  Multiple-objective criteria for optimal experimental design: application to ferrokinetics. , 1985, The American journal of physiology.

[23]  M. Benwell,et al.  Evidence that Tobacco Smoking Increases the Density of (−)‐[3H]Nicotine Binding Sites in Human Brain , 1988, Journal of neurochemistry.

[25]  Raymond E. Gibson,et al.  In vivo dissociation kinetics of [3H]quinuclidinyl benzilate: relationship to muscarinic receptor concentration and in vitro kinetics , 1991, Brain Research.

[26]  C Crouzel,et al.  Cardiac beta-adrenergic receptor density measured in vivo using PET, CGP 12177, and a new graphical method. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[27]  B R Zeeberg,et al.  Theoretical investigation of the estimation of relative regional neuroreceptor concentration from a single SPECT or PET image. , 1990, IEEE transactions on medical imaging.

[28]  B. Winblad,et al.  The role of nicotinic receptors in the pathophysiology of Alzheimer's disease. , 1989, Progress in brain research.

[29]  Raymond F. Muzic,et al.  Temporal alignment of tissue and arterial data and selection of integration start times for the H215O autoradiographic CBF model in PET , 1993, IEEE Trans. Medical Imaging.

[30]  Paul O. Scheibe,et al.  Identifiability Analysis of an In Vivo Receptor-Binding Radiopharmacokinetic System , 1985, IEEE Transactions on Biomedical Engineering.

[31]  A Gelman,et al.  The Precision of Positron Emission Tomography: Theory and Measurement , 1991, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[32]  R H Strasser,et al.  Regulation of β‐Adrenergic Receptors: Impaired Desensitization in Myocardial Ischemia , 1988, Journal of cardiovascular pharmacology.

[33]  J J DiStefano,et al.  Multiexponential, multicompartmental, and noncompartmental modeling. II. Data analysis and statistical considerations. , 1984, The American journal of physiology.

[34]  K Suzuki,et al.  [Age-related decrease of 11C-N-methylspiperone in vivo binding to human striatum detected by PET]. , 1989, Kaku igaku. The Japanese journal of nuclear medicine.

[35]  K Bergström,et al.  In vivo measurement of dopamine receptors in pituitary adenomas using positron emission tomography. , 1986, Acta radiologica. Supplementum.

[36]  R. Huesman.  A new fast algorithm for the evaluation of regions of interest and statistical uncertainty in computed tomography. , 1984, Physics in medicine and biology.

[37]  Christer Halldin,et al.  Central D2-dopamine receptor occupancy in relation to antipsychotic drug effects: A double-blind PET study of schizophrenic patients , 1993, Biological Psychiatry.

[38]  A. Gjedde,et al.  Quantification of Neuroreceptors in the Living Human Brain. I. Irreversible Binding of Ligands , 1986, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.